Abstract
Aims
To determine the impact of tighter glycaemic targets for gestational diabetes.
Methods
Retrospective data analysis before and after introducing tighter glucose targets.
Results
In 2265 pregnancies there was no change in large-for-gestational age babies (Odds ratio (OR) 1.1; 95% Confidence interval (CI) 0.8–1.6) and macrosomia (OR 1.0; 95% CI 0.6–1.7) following tighter glucose targets. Gestational hypertension (OR 0.4; 95% CI 0.2–0.7), spontaneous vaginal birth (OR 0.6; 95% CI 0.4–0.9) reduced and pharmacological treatment increased (OR 2.2; 95% CI 1.7–2.8).
Composite adverse neonatal outcome (perinatal death, shoulder dystocia, fracture, nerve palsy) (OR 0.6; CI 0.02–14.2 p = 0.76)), Apgar<7 at 5 min, neonatal hypoglycaemia, respiratory distress syndrome or neonatal unit admission did not change but neonatal jaundice was reduced (OR 0.4; 95% CI 0.2–0.8).
Conclusions
Tighter glycaemic targets had no impact on large-for-gestational age babies or composite adverse neonatal outcomes. There was reduced spontaneous vaginal birth, gestational hypertension, neonatal jaundice and increased pharmacological treatment.
Keywords
Get full access to this article
View all access options for this article.
